The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies
BackgroundWhile progress has been made in oncology treatments, including the introduction of combination therapies, barriers affect patient access. There are approaches that could improve access including combination-specific pricing that allow the price to reflect whether a product is used in monot...
Saved in:
| Main Authors: | Steven Simoens, David Dodwell, Michael Hartevelt, Peter Lindgren, Michele Pistollato, Lisa Pont, Caridad Pontes, Alexander Roediger, Antun Sablek, Eric Van Ganse, Qinyi Wang, Chris Wenger, Tim Wilsdon, Entela Xoxi, Brian Godman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1532022/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accelerating patient access to oncology medicines with multiple indications in Europe
by: R. Lawlor, et al.
Published: (2021-01-01) -
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017-01-01) -
Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
by: Hajer Dahmani, et al.
Published: (2023-12-01) -
Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview
by: Naina R. Verghese, et al.
Published: (2019-01-01) -
Health technology assessment and reimbursement of pharmaceuticals in Italy
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)